Prestige News

Total 79
Number Thumbnail Title Author Date Votes Views
19 Prestige Biopharma Explores Global Expansion of PAUF-Based Pancreatic Cancer Diagnostic Kit at MEDICA 2023
we******** | 2023.11.16 | Votes 0 | Views 1406
we******** 2023.11.16 0 1406
18 Prestige Biopharma Secures Chinese Patent for PBP1510, a First-in-Class Anti-PAUF Antibody for Pancreatic Cancer
we******** | 2023.11.07 | Votes 0 | Views 1776
we******** 2023.11.07 0 1776
17 Prestige Biopharma Group Signs Strategic CDMO Partnership with Dr. Reddy’s Laboratories
김** | 2023.09.22 | Votes 0 | Views 1890
김** 2023.09.22 0 1890
16 Prestige Biopharma's Busan Innovative Drug Discovery Center (IDC) Designated as Advanced Investment Zone
김** | 2023.09.11 | Votes 0 | Views 1295
김** 2023.09.11 0 1295
15 Prestige Biopharma and Imagion Biosystems Sign an MOU, Developing Early Pancreatic Cancer Diagnosis Platform
김** | 2023.08.11 | Votes 0 | Views 1587
김** 2023.08.11 0 1587
14 Prestige Biopharma Submits EMA Marketing Authorization Application for Herceptin Biosimilar HD201
김** | 2023.07.31 | Votes 0 | Views 1414
김** 2023.07.31 0 1414
13 Prestige Biopharma Receives FDA Fast Track Designation for PBP1510 in the Treatment of Pancreatic Cancer
김** | 2023.03.16 | Votes 0 | Views 1322
김** 2023.03.16 0 1322
12 Prestige Biopharma Initiates Development of PAUF-Based Diagnostic Kit for Pancreatic Cancer
김** | 2023.03.09 | Votes 0 | Views 1309
김** 2023.03.09 0 1309
11 Prestige Biopharma Receives Approval for Phase 1 Trial of Humira Biosimilar in Hungary
김** | 2023.02.15 | Votes 0 | Views 1556
김** 2023.02.15 0 1556
10 Prestige Biopharma Secures Korean Patent for PBP1710, an Antibody Therapeutic for Solid Tumors
김** | 2023.01.10 | Votes 0 | Views 3013
김** 2023.01.10 0 3013